Results 161 to 170 of about 4,843,174 (412)
Yemaya, No. 25, July 2007 [PDF]
, 2007 Battling against Wind and Tide - Latin America/ Uruguay. Women’s Changing Participation - Oceania/ Pacific Islands. From Challenge to Opportunity - Latin America/ Chile. AKTEA Meets Again - European Union. Why Are We in CONAPE?
core
British Journal of Clinical Pharmacology, EarlyView.Aim The benzoxaborole derivative DNDI‐6148 is an antiparasitic agent with activity against multiple Leishmania protozoan species, including L. infantum and L. donovani, which cause visceral leishmaniasis. We investigated the safety, tolerability and pharmacokinetics of single oral doses of DNDI‐6148 in a randomized, parallel‐group, placebo‐controlled ...
Jean‐Yves Gillon +12 more
wiley +1 more source
Operationalisation of social cohesion interventions in Latin America and Europe
The Lancet Global Health, 2016 Michael A Rodriguez, MD +5 more
doaj +1 more source
The White Goods Part Designed Based on DFM/DFA Concepts in a Concurrent Engineering Environment
Brazilian Journal of Operations & Production Management, 2010 The classical way to manage the product development processes for massive production has been changing as the high pressure for cost reduction, higher quality standards and market seeking for innovation lead to the necessity of new tools for development ...
Osiris Canciglieri Junior +2 more
doaj
Renewable Energy Sources and the Problem of Modernizing Institutional Instruments in Latin America
, 2022 Tamara Naumenko, Maria Kozyreva
openalex +1 more source
Quantifying the rural-urban gradient in Latin America and the Caribbean [PDF]
This paper addresses the deceptively simple question: What is the rural population of Latin America and the Caribbean (LAC)? It argues that rurality is a gradient, not a dichotomy, and nominates two dimensions to that gradient: population density and ...
Buys, Piet +2 more
core
Effects of Renal and Hepatic Impairment on the Pharmacokinetics of Zilurgisertib
British Journal of Clinical Pharmacology, EarlyView.Aim Small‐molecule activin receptor‐like kinase‐2 inhibitor zilurgisertib (INCB000928) is under investigation in a pivotal trial for the treatment of fibrodysplasia ossificans progressiva (FOP), an ultrarare genetic condition. This analysis assessed effects of renal and hepatic impairment on zilurgisertib pharmacokinetics.
Yan‐ou Yang +5 more
wiley +1 more source
‘Where are the adults?’: Troubling child‐activism and children's political participation
British Educational Research Journal, EarlyView.Abstract Children's political participation is a well‐established theme in childhood studies. In this article we offer an original account of child activism that takes into account the entangled and emergent aspect of children as activists. We begin with a historical and a conceptual review, noting the importance of mid‐20th century developments such ...
Sharon Hunter, Claire Cassidy
wiley +1 more source